Gene expression profile and mutational analysis of DNA mismatch repair genes in carcinoma prostate in Indian

Abha Soni1, Anju Bansal, L C Singh

  • 1Institute of Pathology, Indian Council of Medical Research, Tumour Biology, New Delhi, India.

Insights

DNA mismatch repair (MMR) gene expression is altered in prostate cancer (Pca). MMR deficiency, particularly hPMS2 loss, correlates with Pca progression and poorer differentiation, suggesting its role as a prognostic marker.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • DNA mismatch repair (MMR) is crucial for maintaining genetic stability.
  • The role of MMR in prostate carcinogenesis is not fully understood.
  • MMR deficiency may have clinical significance in prostate cancer (Pca).

Purpose of the Study:

  • To investigate the gene expression of six key MMR genes in Pca.
  • To analyze polymorphisms in hMLH1 and hMSH2 in the Indian population.
  • To correlate MMR alterations with clinicopathological parameters as potential prognostic markers.

Main Methods:

  • Gene expression profiling of hMLH1, hMSH2, hPMS1, hPMS2, hMSH3, and hMSH6.
  • Analysis of hMLH1 and hMSH2 polymorphisms.
  • Correlation of MMR status with clinicopathological parameters and Gleason score.

Main Results:

  • Significant downregulation of hMLH1, hMSH2, and hPMS2 expression in Pca versus benign prostatic hyperplasia (BPH).
  • Loss of hPMS2 protein observed in poorly differentiated tumors.
  • Inverse correlation between hPMS2 expression and Gleason score.
  • Association of hMLH1-93G>A polymorphism with Pca risk.

Conclusions:

  • Altered DNA mismatch repair (MMR) has significant biological and clinical implications in prostate cancer (Pca).
  • MMR gene expression and polymorphisms may serve as prognostic markers for Pca progression.
  • Further research into MMR's role in Pca pathogenesis is warranted.